 "Lupin, Boehringer Ingelheim ink $700-mn deal for anti-cancer drug")
Lupin plans to set up over a hundred laboratories and a thousand franchisee-based collection centres as it aims to become among the top five diagnostic chains in the country.
The Mumbai-headquartered pharmaceutical company announced its foray in diagnostic business on Friday. The diagnostic sector is fragmented and organised chains have less than 20 per cent share of the overall business. A late entrant in the space, Lupin hopes to scale up the business leveraging its trust with health care professionals and with unique features such as temperature-controlled movement of samples, smart and interactive test reports among others.
Lupin Diagnostics will
